RecruitingNCT04265599
Exploring Pathogenesis and Treatment of Hypercalcemia Caused by Intramuscular Injection of Paraffinoil
Hypercalcemia After Cosmetic Paraffin Oil Injections: Unravelling Etiology, Pathogenesis and Potential Treatments
Sponsor
Herlev Hospital
Enrollment
200 participants
Start Date
Apr 30, 2019
Study Type
OBSERVATIONAL
Conditions
Summary
The aim of the study is to characterize paraffin oil induced granulomatous disease. We will investigate pathogenesis and natural history of paraffin disease. Subsequently, through further translational studies, we intend to identify novel treatments to be tested in future randomized clinical trials.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- previous intramuscular injection of paraffin or other oil
Exclusion Criteria1
- none
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04265599
Related Trials
Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients
NCT049378681 location
Effects of Different Continuous Renal Replacement Therapy Patterns on Ionized Calcium in Patients With Citrate Anticoagulants Using Calcium-containing Replacement Solutions
NCT060210801 location
Hypercalcemia After Paraffin Oil Injection
NCT042922881 location
Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity
NCT039359841 location
Registry for Hypoparathyroidism Wuerzburg
NCT055855931 location